Recalls — last 90 days
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIStop using Medtronic MiniMed insulin pumps
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your Medtronic MiniMed insulin pump position
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your MiniMed insulin pump positioning
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your MiniMed 770G pump position during use
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your MiniMed 780G pump position during use
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIStop using affected Medtronic MiniMed insulin pumps
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your MiniMed 670G insulin pump position
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using affected Civco eTRAX needle sensors
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using Civco eTRAX Needle Sensor
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using Civco eTRAX Needle Sensor 14G
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using Civco eTRAX Needle Sensor 12G
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using Civco eTRAX Needle System Starter Kit
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using Civco eTRAX Needle System Starter Kit
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using Civco eTRAX Needle System Starter Kit
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceCivco Medical Instruments Co. Inc.Class IIStop using Civco eTRAX Needle System Starter Kit
There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.
- 2026-04-08FDA-DeviceMedline Industries, LPClass IIStop using Medline Anterior Hip Pack DYNJ64672B
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
- 2026-04-08FDA-DeviceMedline Industries, LPClass IIMedline kits containing Olympus biopsy valves: 1. BRONCH PROCEDURE KIT, DYKE2091 2. BRONCHSCOPY, DYNJ900898G DYNJ901922I 3. BRONCHSCOPY PACK, DYNJ38313B 4. BRONCHOSCOPY PACK 0120367-LF, DYNJ32750G DYNJ32750I 5. KIT, WR THORACIC, DYNJ911252 6. LARYNGOSCOPY/BRONCHOSCOPY PACK, DYNJ58146B 7. LEX THORACIC, DYNJ902016K DYNJ902016L 8. ORGAN PROCUREMENT, DYNJ908686 9. PULMONARY PACK, DYKE1859 10. THORACIC, DYNJ901666L 11. THORACIC ROBOTICS, DYNJ908777A 12. THORACOTO
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
- 2026-04-08FDA-DeviceMedline Industries, LPClass IIStop using affected Medline bronchoscopy kits
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
- 2026-04-08FDA-DeviceMedline Industries, LPClass IIStop using recalled Medline respiratory kits
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
- 2026-04-08FDA-DeviceMedline Industries, LPClass IIStop using affected Medline thoracic robot kits
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
- 2026-04-08FDA-DeviceMedline Industries, LPClass IIStop using affected Medline bronchoscopy kits immediately
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
- 2026-04-08FDA-DeviceMedline Industries, LPClass IIStop using Medline Airway Exam Kit DYKE1796
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
- 2026-04-08FDA-DeviceSUMMA THERAPEUTICS, LLCClass IIStop using Finesse BTK Multicath catheters
Potential for the balloon in the device to not meet burst specifications.
- 2026-04-08FDA-DeviceSynthes (USA) Products LLCClass IIStop using Synthes VOLT Cortex Screw lot 68982P8
A full lot swap between VOLT Locking Screw Tap 03.424.124 lot 68900P9 and Cortical Screw Tap 03.424.126 lot 68982P8, resulting in the bones taps having an incorrect thread.
- 2026-04-08FDA-DeviceSynthes (USA) Products LLCClass IICheck Synthes bone tap lot 68900P9 immediately
A full lot swap between VOLT Locking Screw Tap 03.424.124 lot 68900P9 and Cortical Screw Tap 03.424.126 lot 68982P8, resulting in the bones taps having an incorrect thread.
- 2026-04-08FDA-DeviceIntuitive Surgical, Inc.Class IIStop using affected da Vinci cautery hook instruments
Due to increased in complaints regarding frayed or broken pitch cables on reusable surgical instruments
- 2026-04-08FDA-DeviceIntuitive Surgical, Inc.Class IICheck da Vinci Tenaculum Forceps for cable damage
Due to increased in complaints regarding frayed or broken pitch cables on reusable surgical instruments
- 2026-04-08FDA-DeviceIntuitive Surgical, Inc.Class IIStop using affected da Vinci grasping retractors
Due to increased complaints for broken/frayed grip cables for reusable instruments.
- 2026-04-08FDA-DeviceIntuitive Surgical, Inc.Class IIStop using da Vinci Mega Needle Driver instruments
Due to increased complaints for broken/frayed grip cables for reusable instruments.
- 2026-04-08FDA-DeviceIntuitive Surgical, Inc.Class IIStop using affected da Vinci grasper instruments
Due to increased complaints for broken/frayed grip cables for reusable instruments.